Related Experiment Video
Updated: Mar 14, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Building Cell Selectivity into CPP-Mediated Strategies
Irene Martín1, Meritxell Teixidó2, Ernest Giralt3,4
1Institute for Research in Biomedicine (IRB Barcelona), Barcelona Science Park, Baldiri Reixac 10, Barcelona, Spain. irene.martin@irbbarcelona.org.
Abstract:
There is a pressing need for more effective and selective therapies for cancer and other diseases. Consequently, much effort is being devoted to the development of alternative experimental approaches based on selective systems, which are designed to be specifically directed against target cells. In addition, a large number of highly potent therapeutic molecules are being discovered. However, they do not reach clinical trials because of their low delivery, poor specificity or their incapacity to bypass the plasma membrane. Cell-penetrating peptides (CPPs) are an open door for cell-impermeable compounds to reach intracellular targets. Putting all these together, research is sailing in the direction of the design of systems with the capacity to transport new drugs into a target cell. Some CPPs show cell type specificity while others require modifications or form part of more sophisticated drug delivery systems. In this review article we summarize several strategies for directed drug delivery involving CPPs that have been reported in the literature.
Insights
Cell-penetrating peptides (CPPs) offer a solution for delivering potent therapeutic molecules intracellularly. This review explores CPP-based strategies for targeted drug delivery to improve cancer therapies.
Area of Science:
- Biomedical Engineering
- Molecular Biology
- Pharmacology
Background:
- Developing effective and selective therapies for diseases like cancer remains a significant challenge.
- Many potent therapeutic molecules fail clinical trials due to poor delivery, low specificity, or inability to cross cell membranes.
Approach:
- Cell-penetrating peptides (CPPs) are explored as a method to facilitate the intracellular delivery of cell-impermeable compounds.
- Research focuses on designing drug delivery systems that utilize CPPs for targeted transport into specific cells.
- Strategies involve modifying CPPs or integrating them into sophisticated delivery systems to enhance targeting and efficacy.
Key Points:
- CPPs can overcome the plasma membrane barrier, enabling intracellular access for therapeutic agents.
- Some CPPs exhibit inherent cell type specificity, while others require modifications for targeted delivery.
- The integration of CPPs into advanced drug delivery systems is a key area of research.
Conclusions:
- CPPs represent a promising strategy for enhancing the delivery and specificity of novel therapeutics.
- Further development of CPP-based systems could overcome current limitations in drug delivery, leading to more effective treatments.
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
09:16In Vitro Directed Evolution of a Restriction Endonuclease with More Stringent Specificity
Published on: March 25, 2020
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...